GlassScriptPhysician profile
Michelle Y Perry
NPI 1710099429
$769.75
in general payments reported to CMS, 2019-2025
15 companies · $92.32 in 2025
The $92.32 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34.16 · 2020: $33.66 · 2021: $240 · 2022: $69.50 · 2023: $67.89 · 2024: $232 · 2025: $92.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $324 · Education: $67.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $324.17 |
| Education | $67.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $260.84 | 2023-2024 | Veozah |
| Abbvie INC. | $207.14 | 2019-2021 | |
| Pfizer INC. | $64.73 | 2021-2025 | |
| Alydia Health | $42.40 | 2021 | |
| Mayne Pharma Commercial LLC | $37.70 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.12 | 2025 | |
| Therapeuticsmd, INC. | $20.52 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $17.75 | 2021 | |
| Abbott Laboratories | $16.61 | 2025 | |
| Organon LLC | $16.55 | 2025 | Nexplanon |
| Evofem Biosciences, INC. | $14.96 | 2022 | |
| Agile Therapeutics, INC. | $13.87 | 2023 | Twirla |
| Covidien LP | $13.78 | 2019 | |
| Avion Pharmaceuticals | $11.77 | 2022 | |
| Aspira Women'S Health INC | $7.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Perry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.